518.69
-12.31 (-2.32%)
| 前收盘价格 | 531.00 |
| 收盘价格 | 532.91 |
| 成交量 | 233,038 |
| 平均成交量 (3个月) | 455,889 |
| 市值 | 14,571,572,224 |
| 市盈率 (P/E TTM) | 38.62 |
| 预期市盈率 (P/E Forward) | 36.23 |
| 价格/销量 (P/S) | 7.47 |
| 股市价格/股市净资产 (P/B) | 87.40 |
| 52周波幅 | |
| 利润日期 | 22 Oct 2025 |
| 营业毛利率 | 19.31% |
| 营业利益率 (TTM) | 20.32% |
| 稀释每股收益 (EPS TTM) | 13.10 |
| 季度收入增长率 (YOY) | 9.30% |
| 季度盈利增长率 (YOY) | 11.70% |
| 总债务/股东权益 (D/E MRQ) | 25.33% |
| 流动比率 (MRQ) | 0.730 |
| 营业现金流 (OCF TTM) | 581.97 M |
| 杠杆自由现金流 (LFCF TTM) | 433.28 M |
| 资产报酬率 (ROA TTM) | 15.44% |
| 股东权益报酬率 (ROE TTM) | 65.82% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 看涨 | 混合的 |
| Diagnostics & Research (全球的) | 看涨 | 混合的 | |
| 股票 | Medpace Holdings, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | -2.5 |
| 内部交易活动 | NA |
| 价格波动 | -3.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.5 |
| 平均 | -1.25 |
|
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Mid Growth |
| 内部持股比例 | 20.55% |
| 机构持股比例 | 91.47% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 575.00 (Mizuho, 10.86%) | 购买 |
| 中 | 436.00 (-15.94%) | |
| 低 | 305.00 (UBS, -41.20%) | 卖出 |
| 平均值 | 439.00 (-15.36%) | |
| 总计 | 1 购买, 5 保留, 3 卖出 | |
| 平均价格@调整类型 | 469.85 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Mizuho | 17 Oct 2025 | 575.00 (10.86%) | 购买 | 528.07 |
| 25 Jul 2025 | 510.00 (-1.68%) | 购买 | 447.49 | |
| Barclays | 02 Oct 2025 | 425.00 (-18.06%) | 卖出 | 536.17 |
| 23 Jul 2025 | 450.00 (-13.24%) | 保留 | 437.41 | |
| Jefferies | 09 Sep 2025 | 450.00 (-13.24%) | 保留 | 485.59 |
| Rothschild & Co | 03 Sep 2025 | 474.00 (-8.62%) | 保留 | 481.23 |
| UBS | 29 Jul 2025 | 305.00 (-41.20%) | 卖出 | 447.92 |
| Baird | 23 Jul 2025 | 490.00 (-5.53%) | 保留 | 437.41 |
| Deutsche Bank | 23 Jul 2025 | 430.00 (-17.10%) | 保留 | 437.41 |
| TD Cowen | 23 Jul 2025 | 366.00 (-29.44%) | 卖出 | 437.41 |
| Truist Securities | 23 Jul 2025 | 436.00 (-15.94%) | 保留 | 437.41 |
| 显示更多 | ||||
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 23 Sep 2025 | 公告 | Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合